2028年までの欧州血尿治療市場予測 - 治療（薬剤、治療法、その他）、適応症（尿路感染症、腎臓結石、尿道炎、血液がん、膀胱結石、前立腺がん、膀胱炎、外傷、激しい運動、多発性嚢胞腎、子宮内膜症、月経）、タイプ（肉眼的血尿、顕微鏡的血尿、特発性血尿、ジョガー血尿）、エンドユーザー（病院、診療所、外来手術センターなど）
市場紹介
血尿は、尿中に血液が認められる病状です。 。一般に、尿には赤血球が含まれていないため、腎臓結石、尿路感染症、その他の遺伝性疾患を引き起こす可能性のある深刻な問題が発生する可能性があります。
さらに、血尿の有病率が高いため、関連する兆候は、予測期間中に市場の成長を促進すると予想されます。しかし、関連する適応症の未診断症例が欧州の血尿治療市場の成長を制限しています。
さまざまな患者が、入院時および入院中に進行性の急性腎障害（AKI）を報告しています。血尿に対する軽度のタンパク尿症状。これは、COVID 19 の入院患者における有害な臨床転帰と関連しています。タンパク尿と血尿は、AKI よりも COVID-19 における有病率がさらに高いと報告されています。中国での遡及研究では、タンパク尿と血尿が新型コロナウイルス感染症と関連し、死亡率が高いことが報告されている。さらに、2020年3月に設立された欧州腎臓協会（ERACODA）の新型コロナウイルス感染症データベースによると、腎臓移植患者の約25％がコロナウイルスと診断されている。したがって、新型コロナウイルス陽性患者の増加により、腎臓病の治療を受ける可能性が高まると予想されます。
市場の概要とダイナミクス
ヨーロッパの血尿治療市場は、2021 年の 2 億 7,050 万米ドルから 2028 年までに 3 億 1,380 万米ドルに達すると予測されています。 2021 年から 2028 年までに 2.1% の CAGR で成長すると予想されています。この地域の患者のほとんどは在宅ケア サービスを好みます。ウェアラブルおよびポータブル医療機器は、患者が透析プロセスと並行して日常生活を継続できるようにすることで、治療を改善する大きな可能性を秘めています。たとえば、在宅透析では、患者の仕事やライフスタイルのスケジュールに大きな柔軟性が与えられます。さらに、在宅血液透析の全体的な手順は、従来の透析と比較してはるかに簡素化されています。したがって、ウェアラブルおよび埋め込み型デバイスは、患者が治療中に仕事や日常活動を自由に行えるようにする可能性があります。このような先進的な代替治療法は、今後数年間でヨーロッパの血尿治療市場を牽引すると考えられます。
主要市場セグメント
2020 年の欧州血尿治療市場では、種類別に肉眼的血尿セグメントが最大のシェアを占めました。治療に関しては医薬品セグメントが最大のシェアを占めました。 2020年のヨーロッパの血尿治療市場。適応症に関しては、尿路感染症セグメントが2020年のヨーロッパ血尿治療市場で最大のシェアを占めました。エンドユーザーに関しては、病院セグメントがヨーロッパの血尿治療市場で最大のシェアを占めました。 2020 年の治療市場。
リストされている主要供給源と企業
<スパン>ヨーロッパの血尿治療市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、特に企業のウェブサイト、年次報告書、財務報告書、政府文書、統計データベースなどです。報告書に記載されている主要企業は、アストラゼネカ、ブリストル・マイヤーズ スクイブ社、F. ホフマン・ラ・ロッシュ社、グラクソ・スミスクライン社、ヤンセン・ファーマシューティカルズ社、メルク・アンド・ヘルスケア社などです。 Co., Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd、および Boehringer Ingelheim International GmbH。
レポートを購入する理由
- ヨーロッパの血尿治療市場の状況を理解し、次のような市場セグメントを特定します。高い収益が保証される可能性が高い
- 絶えず変化する市場環境を理解し、競争で優位に立つため
- 効率的に最も売上が見込めるセグメントを特定することにより、欧州血尿治療市場における合併・買収およびパートナーシップ取引を計画する
- 市場の知覚的かつ包括的な分析に基づいて、知識に基づいたビジネス上の意思決定を行うためさまざまなセグメントのパフォーマンス
- 2021年から2028年の期間のさまざまなセグメントに基づいたヨーロッパ血尿治療市場の市場収益予測を取得するため
ヨーロッパの血尿治療市場セグメンテーション
作成者 >治療
- 薬
- 療法
- その他
適応症別
- 尿路感染症
- 腎臓結石
- 尿道炎
- 血液がん
- 膀胱結石
- 前立腺がん
- 膀胱炎
- 外傷
- 激しい運動
- 多発性嚢胞腎
- 子宮内膜症
- 月経
タイプ別
- 肉眼的血尿
- 顕微鏡的血尿
- 特発性血尿
- < span>ジョガーの血尿
エンド ユーザー別
< ul>国別
- ヨーロッパ
- ドイツ
- イギリス
- フランス
- スペイン
- イタリア
- その他のヨーロッパ
言及された企業
- < scan>アストラゼネカ
- ブリストル・マイヤーズ スクイブ社
- F.ホフマン・ラ・ロッシュ株式会社
- グラクソ・スミスクライン plc.
- ヤンセン・ファーマシューティカルズ
- メルク＆メルク社株式会社
- ノバルティス AG
- ファイザー株式会社
- < span>サンファーマシューティカルインダストリーズ株式会社
- ベーリンガーインゲルハイムインターナショナルGmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Hematuria Treatment Market – By Treatment
1.3.2 Europe Hematuria Treatment Market – By Indication
1.3.3 Europe Hematuria Treatment Market – By Type
1.3.4 Europe Hematuria Treatment Market – By End User
1.3.5 Europe Hematuria Treatment Market – By Country
2. Europe Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Europe Analysis
6.1 Europe Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Europe Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Europe Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Europe Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Europe Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Hematuria Treatment Market – Geographic Analysis
11.1 Europe: Hematuria Treatment Market
11.1.1 Overview
11.1.2 Europe: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 Europe: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.4 Europe: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.5 Europe: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.6 Europe: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7 Europe: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.7.1 Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 Germany: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.1.3 Germany: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.1.4 Germany: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.1.5 Germany: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.2 France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 France: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.2.3 France: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.2.4 France: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.2.5 France: Hematuria Treatment Market, by End user, 2019–2028 (US$ Million)
11.1.7.3 UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 UK: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.3.3 UK: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.3.4 UK: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.3.5 UK: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.4 Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.1 Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.2 Italy: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.4.3 Italy: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.4.4 Italy: Hematuria Treatment Market, by Type, 2019-2028 (US$ Million)
11.1.7.4.5 Italy: Hematuria Treatment Market, by End User, 2019-2028 (US$ Million)
11.1.7.5 Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.1 Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.2 Spain: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.5.3 Spain: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.5.4 Spain: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.5.5 Spain: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.6 Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.1 Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.2 Rest of Europe: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.6.3 Rest of Europe: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.6.4 Rest of Europe: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.6.5 Rest of Europe: Hematuria Treatment Market, By End User, 2019–2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 2. Europe: Hematuria Treatment Market, By Indication– Revenue and Forecast to 2028 (US$ Million)
Table 3. Europe Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Europe Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Germany: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Hematuria Treatment Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 13. UK: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 14. UK: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Europe: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Europe: Hematuria Treatment Market, By Indication– Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Europe: Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Europe: Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Europe Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. UK to Show Significant Growth During Forecast Period
Figure 5. Europe Hematuria Treatment Market, Industry Landscape
Figure 6. Europe PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Europe Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. Europe Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Europe Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. Europe Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. Europe: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 37. Europe Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Europe: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 46. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.